References
  1. Murao N, Ishigai M, Yasuno H, et al. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom. 2007;21(24):4033-8.
  2. Sakamoto S, Kawabata H, Kanda J, et al. High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation.Cancer Med . 2017;6(1):120-8
  3. Ganz T and Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823(9):1434-43.
  4. Ganz T. Hepcidin. Rinsho Ketsueki. 2016;57(10):1913-7.
  5. Silvestri L, Nai A, Dulja A and Pagani A. Hepcidin and the BMP-SMAD pathway: an unexpected liaison. Vitam Horm . 2019;110:71-99.
  6. Huang Y, Kuo H, Huang F, et al. Hepcidin-induced iron deficiency is related to transient anemia and hypoferremia in Kawasaki disease patients. Int J Mol Sci . 2016;17(5):715.
  7. Kuo H, Yang Y, Chuang J, et al. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesion in Kawasaki disease. J. Clin. Immunol . 2012;32(4):746-52.